Results 261 to 270 of about 8,252,790 (324)
Some of the next articles are maybe not open access.
Impact of Drug Approval Pathways for Paediatric Inflammatory Bowel Disease.
Journal of Crohn's & Colitis, 2021BACKGROUND AND AIMS Timely access to approved medications is a priority in paediatric inflammatory bowel disease (IBD). To date, the timing of drug studies in paediatric IBD has been suboptimal with most studies conducted long after approval has been ...
E. Crowley +5 more
semanticscholar +1 more source
Journal of Clinical Oncology, 2022
PURPOSE Clinical trial evidence is routinely evaluated for initial drug approvals, yet the benefit of indication extensions remains uncertain. This study evaluates the clinical benefit supporting new cancer drugs' initial and supplemental US Food and ...
D. Michaeli, T. Michaeli
semanticscholar +1 more source
PURPOSE Clinical trial evidence is routinely evaluated for initial drug approvals, yet the benefit of indication extensions remains uncertain. This study evaluates the clinical benefit supporting new cancer drugs' initial and supplemental US Food and ...
D. Michaeli, T. Michaeli
semanticscholar +1 more source
Drug Approval and Drug Effectiveness
Annual Review of Clinical Psychology, 2014Data on the efficacy and safety of psychiatric medicines should form the foundation of evidence-based treatment practices. The US Food and Drug Administration (FDA) reviews such data in determining whether to approve new treatments, and the published literature serves as a repository for evidence on treatment benefits and harms.
Glen I, Spielmans, Irving, Kirsch
openaire +2 more sources
The American Journal of Medicine, 2021
In 2020, the US Food and Drug Administration approved 53 novel drugs. Thirty-six of the 53 (68%) drugs were reviewed and approved through an expedited review pathway, and 31 of the 53 (58%) were approved for treatment of a rare disease. This review includes a summary of the novel drugs approved by the US Food and Drug Administration in 2020.
Alex M Ebied +2 more
openaire +2 more sources
In 2020, the US Food and Drug Administration approved 53 novel drugs. Thirty-six of the 53 (68%) drugs were reviewed and approved through an expedited review pathway, and 31 of the 53 (58%) were approved for treatment of a rare disease. This review includes a summary of the novel drugs approved by the US Food and Drug Administration in 2020.
Alex M Ebied +2 more
openaire +2 more sources
Drug Approval and Surveillance
International Journal of Gynecology & Obstetrics, 1980ABSTRACTThe author proposes that current regulations governing the licensing of drugs, particularly in the United States, need to be changed and replaced by a system of provisional or conditional licensing and increased postmarketing surveillance of drug use.
openaire +2 more sources
Science, 2017
As the Trump administration takes shape, there is much speculation as to what major changes will be made. A dominant theme of the Trump campaign was to cut through bureaucracy in Washington, D.C., thereby enhancing innovation and bringing new technology to Americans more quickly.
openaire +2 more sources
As the Trump administration takes shape, there is much speculation as to what major changes will be made. A dominant theme of the Trump campaign was to cut through bureaucracy in Washington, D.C., thereby enhancing innovation and bringing new technology to Americans more quickly.
openaire +2 more sources
Drugs approved for small ruminants
Journal of the American Veterinary Medical Association, 2004JAVMA, Vol 224, No. 4, February 15, 2004 F the purpose of this FARAD Digest, small ruminants are considered to include sheep, goats, deer, and camelids. In the United States, the small ruminant population is low, and they are all considered minor species under the Food, Drug, and Cosmetics Act (Table 1).
Alistair I, Webb +4 more
openaire +2 more sources
Journal of Controlled Release, 2018
According to the Alzheimer Association Report (2017), Alzheimer's disease (AD) is the 6th primary cause of death in the USA, which affects nearly 5.5 million people.
M. Agrawal +6 more
semanticscholar +1 more source
According to the Alzheimer Association Report (2017), Alzheimer's disease (AD) is the 6th primary cause of death in the USA, which affects nearly 5.5 million people.
M. Agrawal +6 more
semanticscholar +1 more source
Characteristics of expedited programmes for cancer drug approval in China
Nature reviews. Drug discovery, 2021Guan-Qiao Li +4 more
semanticscholar +1 more source

